08/11/2020 - National Institutes of Health (NIH) Research Updates – August 2020 The National Institutes of Health (NIH) is our nation’s medical research agency and strives to make scientific discoveries that improve health and save lives. Founded in 1870, the NIH conducts its own scientific research through its Intramural Research Program (IRP), which supports approximately 1,200 principal investigators and more than 4,000 postdoctoral fellows conducting basic, translational and clinical research. In this blog, we will highlight recent ground-breaking NIH research.
08/11/2020 - Guide to Laboratory Information Management System Software Validations Clinical laboratories are often uncertain about the requirements for validation across the Laboratory Information Management System (LIMS) lifecycle. After your laboratory adopts a new LIMS, you must perform a full LIMS validation prior to using...
08/11/2020 - Autoscribe Publishes New Medical Devices Case Study Autoscribe Informatics has just released a new case study in conjunction with Swiss Precision Diagnostics (SPD) who have replaced their legacy Laboratory Information Management System (LIMS) with Matrix Gemini. The new LIMS integrates data from volunteer sample collection, laboratory testing and a clinical biobank to provide integrated data management across their organization.
08/11/2020 - LIMS Data Analytics and Visualization LIMS Data Analytics and Visualization tools graphically present data from your LIMS, and potentially other applications, to provide powerful business intelligence for your laboratory and organization. Like all LIMS, Matrix Gemini uses a relational database (usually Microsoft SQL or Oracle) to store the LIMS data.
08/11/2020 - Sunquest Physician Portal SM for Sunquest Mitogen ™ LIMS For start-up or esoteric labs looking to offer molecular testing to a broader range of customers, Sunquest Mitogen LIMS can be deployed with a physician portal built specifically for this purpose and more. Increase your reach, automate orders and results, improve on quality, and extend your brand.
08/11/2020 - Thermo Fisher Scientific Develops COVID-19 Antibody Assay Targeting Transplant Community Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). The assay will be provided under the company's One Lambda brand representing leading in vitro diagnostic products for the transplant community. |